Imed Pu(IL:IMED)
ILAÂ 77.800.00 (0.00%)
IL:IMED
Imed Pu financials statements
ILAÂ 77.80
At close:0.00 (0.00%)
Imed Pu (IMED) Ratios
0 Followers
Imed Pu Ratios
IL:IMED's free cash flow for Q4 2025 was $-155.04K. For the 2025 fiscal year, IL:IMED's free cash flow was increased by $0.00 and operating cash flow was $-155.04K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 8.00 | 11.03 | 17.56 | 25.33 |
| Quick Ratio | 0.00 | 8.00 | 11.03 | 17.56 | 25.33 |
| Cash Ratio | 0.00 | 7.89 | 10.89 | 15.87 | 24.30 |
| Solvency Ratio | -0.79 | 0.05 | -0.26 | -2.81 | 0.73 |
| Operating Cash Flow Ratio | 0.00 | -5.71 | -4.29 | -9.32 | -5.16 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.71M | $ 784.00K | $ 1.42M | $ 2.30M | $ 4.26M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.27 | 1.01 | 1.02 | 1.01 | 1.02 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | -46.84 | -1.57 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.10 | 0.00 |
| Net Debt to EBITDA | 13.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | -1417.07% | 183.97% | -307.50% | -1190.67% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -1417.07% | 183.97% | -307.50% | -1190.67% |
| Pretax Profit Margin | 0.00% | -1402.44% | 187.90% | -503.00% | -1021.33% |
| Net Profit Margin | 0.00% | -1402.44% | 187.90% | -503.00% | -1021.33% |
| Continuous Operations Profit Margin | 0.00% | -1402.44% | 187.90% | -503.00% | -1021.33% |
| Net Income Per EBT | 70.83% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 45.07% | 98.97% | 102.14% | 163.58% | 85.78% |
| Return on Assets (ROA) | -1.83% | -7.52% | -21.45% | -10.04% | -6.93% |
| Return on Equity (ROE) | -2.33% | -7.63% | -21.82% | -10.18% | -7.04% |
| Return on Capital Employed (ROCE) | -5.73% | -7.71% | -21.37% | -6.22% | -8.20% |
| Return on Invested Capital (ROIC) | -5.73% | -7.71% | -21.37% | -6.22% | -8.20% |
| Return on Tangible Assets | -1.83% | -7.52% | -21.45% | -10.04% | -6.93% |
| Earnings Yield | -8.49% | -45.79% | -147.26% | -58.42% | -18.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.01 | -0.11 | 0.02 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.04 | -0.51 | 0.06 | 0.01 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | -0.16 | -0.15 | -0.32 | -0.22 |
| Free Cash Flow Per Share | -0.08 | -0.16 | -0.15 | -0.32 | -0.22 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -15.59 | 0.65 | -6.48 | -12.04 |
| Free Cash Flow Yield | -21.22% | -50.89% | -50.67% | -75.26% | -21.72% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.18 | -2.18 | -0.68 | -1.71 | -5.43 |
| Price-to-Sales (P/S) Ratio | 0.00 | 30.63 | -1.28 | 8.61 | 55.44 |
| Price-to-Book (P/B) Ratio | 0.27 | 0.17 | 0.15 | 0.17 | 0.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.71 | -1.97 | -1.97 | -1.33 | -4.60 |
| Price-to-Operating Cash Flow Ratio | -4.71 | -1.97 | -1.97 | -1.33 | -4.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | 0.03 | -0.01 | -0.05 | -0.01 |
| Enterprise Value Multiple | 5.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value | -1.15M | 371.71K | -345.04K | -483.89K | -93.70K |
| EV to EBITDA | 5.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Sales | 0.00 | 9.07 | 0.37 | -2.42 | -1.25 |
| EV to Free Cash Flow | 3.12 | -0.58 | 0.57 | 0.37 | 0.10 |
| EV to Operating Cash Flow | 3.12 | -0.58 | 0.57 | 0.37 | 0.10 |
| Tangible Book Value Per Share | 1.73 | 1.83 | 2.02 | 2.46 | 2.70 |
| Shareholders’ Equity Per Share | 1.39 | 1.83 | 2.02 | 2.46 | 2.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.01 | -0.23 | 0.05 | 0.02 |
| Net Income Per Share | -0.03 | -0.14 | -0.44 | -0.25 | -0.19 |
| Tax Burden | 0.71 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 0.99 | 1.02 | 1.64 | 0.86 |
| Research & Development to Revenue | 0.00 | 434.15 | -16.99 | 53.00 | 136.00 |
| SG&A to Revenue | 0.00 | 15.17 | -0.83 | 3.92 | 12.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 |
| Income Quality | 2.50 | 1.11 | 0.34 | 1.29 | 1.18 |
Currency in USD
